In addition, GPR162-WT (1.22 ± 0.064, p < 0.001) and GPR162-R218* (1.17 ± 0.059, p < 0.05) overexpression increased corticotroph tumor cell proliferation compared with empty vector control (Fig. 2D). The gene discussed is GPR162; the disease is neoplasm.